Prepare for your visit
Frank De George
Optometrist · Lodi, NJ · NPI 1215090436
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$857.63
in general payments reported to CMS, 2019-2025 · $125 in 2025
The $125 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Who reported paying
General payments only, top 6 by amount.
- Allergan, INC. $281.23
- Bausch & Lomb Americas INC. $124.73
- Coopervision INC. $121.29
- Rxsight INC $113.89
- Carl Zeiss Meditec, INC. $100.00
- Oyster Point Pharma, INC. $97.09
Drugs and devices associated with these payments
Miebo Xiidra Myday Contact Lens Rxsight Injector Handpiece Rxsight Light Delivery Device (Ldd) Rxsight Contact Lens Rxsight Injector Cartridge Rxsight Light Adjustable Lens (Rxlal) Tyrvaya
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Frank De George listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/796276/frank-de-george